YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.42
+0.03 (+7.24%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +6,609.9% upside
Low Target $15.39
Average Target $27.92
High Target $30.56
Current Price $0.42
Current
$0.42
Target
$27.92
$15.39 $27.92 avg $30.56
Scenario Analysis
Bear Case
$15.39
3,598.6%
Low target
Base Case
$27.92
+6,609.9%
Avg target
Bull Case
$30.56
+7,244.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.56
-83.7% from high
52-Week Low
$0.33
+26.1% from low
Target vs 52W High
$27.92
+990.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%